Tiberio, F., Salvati, M., Polito, L., Tisci, G., Vita, A., Parolini, O., . . . Lattanzi, W. Targeted allele-specific FGFR2 knockdown via human recombinant ferritin nanoparticles for personalized treatment of Crouzon syndrome. Elsevier.
Chicago Style (17th ed.) CitationTiberio, Federica, et al. Targeted Allele-specific FGFR2 Knockdown via Human Recombinant Ferritin Nanoparticles for Personalized Treatment of Crouzon Syndrome. Elsevier.
MLA (9th ed.) CitationTiberio, Federica, et al. Targeted Allele-specific FGFR2 Knockdown via Human Recombinant Ferritin Nanoparticles for Personalized Treatment of Crouzon Syndrome. Elsevier.
Warning: These citations may not always be 100% accurate.